With the new unit, Bellvitge continues to roll out a new model of mental health care that enhances patient autonomy and eliminates the stigma surrounding these conditions.

The goal is to provide a comprehensive approach, with flexible, personalized, and close care, involving patients and their families in the process.

From November 26 to 29, the 7th edition of the Mapping Course Bellvitge is taking place at Bellvitge Hospital and the Bellvitge University Campus, where the latest advances in neurosurgery with intraoperative mapping, neurophysiological monitoring, and surgical neuropsychological assessment are being presented.

An international multicenter study, involving the Bellvitge University Hospital and IDIBELL, has shown that the drug semaglutide, designed to treat diabetes and obesity, protects the kidney in obese non-diabetic patients with chronic kidney disease.

The procedure was carried out by the renowned surgeon Diego González Rivas, in collaboration with thoracic surgeons from Bellvitge Hospital and a large multidisciplinary team. 

The minimally invasive robotic approach marks a milestone in the treatment of high-complexity tumors.

It has modernized equipment and facilities with cutting-edge technology and digitization.

In 2023, the department performed 40,295 biopsies and surgical specimen studies, as well as 32,918 cytologies.

This event is free of charge and open to the entire community of patients, family members, and interested individuals.